TRAF3 Antikörper (AA 1-40) (FITC)
-
- Target Alle TRAF3 Antikörper anzeigen
- TRAF3 (TNF Receptor-Associated Factor 3 (TRAF3))
-
Bindungsspezifität
- AA 1-40
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TRAF3 Antikörper ist konjugiert mit FITC
- Applikation
- Bitte anfragen
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human TNF receptor-associated factor 3 protein (1-40AA)
- Isotyp
- IgG
- Top Product
- Discover our top product TRAF3 Primärantikörper
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- TRAF3 (TNF Receptor-Associated Factor 3 (TRAF3))
- Andere Bezeichnung
- TRAF3 (TRAF3 Produkte)
- Synonyme
- CAP-1 antikoerper, CAP1 antikoerper, CD40bp antikoerper, CRAF1 antikoerper, IIAE5 antikoerper, LAP1 antikoerper, AI528849 antikoerper, T-BAM antikoerper, amn antikoerper, TNF receptor associated factor 3 antikoerper, TNF receptor-associated factor 3 antikoerper, Tnf receptor-associated factor 3 antikoerper, TRAF3 antikoerper, Traf3 antikoerper
- Hintergrund
-
Background: Regulates pathways leading to the activation of NF-kappa-B and MAP kinases, and plays a central role in the regulation of B-cell survival. Part of signaling pathways leading to the production of cytokines and interferon. Required for normal antibody isotype switching from IgM to IgG. Plays a role T-cell dependent immune responses. Plays a role in the regulation of antiviral responses. Is an essential constituent of several E3 ubiquitin-protein ligase complexes. May have E3 ubiquitin-protein ligase activity and promote \'Lys-63\'-linked ubiquitination of target proteins. Inhibits activation of NF-kappa-B in response to LTBR stimulation. Inhibits TRAF2-mediated activation of NF-kappa-B. Down-regulates proteolytic processing of NFKB2, and thereby inhibits non-canonical activation of NF-kappa-B. Promotes ubiquitination and proteasomal degradation of MAP3K14.
Aliases: CAP 1 antibody, CAP-1 antibody, CAP1 antibody, CD40 associated protein 1 antibody, CD40 binding protein antibody, CD40 bp antibody, CD40 receptor associated factor 1 antibody, CD40 receptor-associated factor 1 antibody, CD40-binding protein antibody, CD40BP antibody, CRAF 1 antibody, CRAF1 antibody, IIAE5 antibody, LAP 1 antibody, LAP1 antibody, LMP1 associated protein antibody, LMP1-associated protein 1 antibody, MIPT3 antibody, TNF receptor associated factor 3 antibody, TNF receptor-associated factor 3 antibody, TRAF 3 antibody, Traf3 antibody, TRAF3_HUMAN antibody
- UniProt
- Q13114
- Pathways
- NF-kappaB Signalweg, Apoptose, TLR Signalweg, Activation of Innate immune Response, Hepatitis C, Toll-Like Receptors Cascades
-